Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study of ALPN-101 in Systemic Lupus Erythematosus

NCT04835441 is registered in ClinicalTrials.gov with Alpine Immune Sciences Inc, A Subsidiary of Vertex as lead sponsor.

NCT NCT04835441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04835441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study of ALPN-101 in Systemic Lupus Erythematosus
Lead sponsor
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase
Phase 2
Overall status
Completed
Start date
June 22, 2021
Completion date
July 9, 2024
Enrollment
76 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus